Lung Therapeutics careers
Lung Therapeutics leverages validated programs to develop first in class medicines for unmet needs in lung injury and disease. Lead compound LTI-01 is entering phase I trials for loculated pleural effusions, a severe consequence of pneumonia with no approved therapeutic options. In preclinical stage, LTI-03 has shown the ability to resolve established fibrosis in idiopathic pulmonary fibrosis and other fibrotic indications. These areas of great unmet medical need make for a more than billion dollar opportunity for Lung Therapeutics.
Lung Therapeutics hasn't added any jobs yet
Get notified when Lung Therapeutics posts new jobs.
Brian Windsor
CEO Lung Therapeutics • Studied at @University of Texas at Austin
SRI International • Ann Arbor • $102k – $135k • 2 weeks ago
Interplay Learning • Austin • $80k – $90k • 3 weeks ago
Ptc Therapeutics • United States • $119k – $145k • 3 weeks ago
Gilead Sciences • Foster City • $210k – $272k • 3 weeks ago
Eli Lilly • Indianapolis • $69k – $165k • 4 weeks ago
